Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Cancer origins-genetics rules the day.

Kareta MS, Sage J.

Science. 2018 Oct 5;362(6410):30-31. doi: 10.1126/science.aav1044. No abstract available.

PMID:
30287650
2.

Myt1l safeguards neuronal identity by actively repressing many non-neuronal fates.

Mall M, Kareta MS, Chanda S, Ahlenius H, Perotti N, Zhou B, Grieder SD, Ge X, Drake S, Euong Ang C, Walker BM, Vierbuchen T, Fuentes DR, Brennecke P, Nitta KR, Jolma A, Steinmetz LM, Taipale J, Südhof TC, Wernig M.

Nature. 2017 Apr 13;544(7649):245-249. doi: 10.1038/nature21722. Epub 2017 Apr 5.

PMID:
28379941
3.

Identification and Targeting of Long-Term Tumor-Propagating Cells in Small Cell Lung Cancer.

Jahchan NS, Lim JS, Bola B, Morris K, Seitz G, Tran KQ, Xu L, Trapani F, Morrow CJ, Cristea S, Coles GL, Yang D, Vaka D, Kareta MS, George J, Mazur PK, Nguyen T, Anderson WC, Dylla SJ, Blackhall F, Peifer M, Dive C, Sage J.

Cell Rep. 2016 Jul 19;16(3):644-56. doi: 10.1016/j.celrep.2016.06.021. Epub 2016 Jun 30.

4.

Crosstalk between stem cell and cell cycle machineries.

Kareta MS, Sage J, Wernig M.

Curr Opin Cell Biol. 2015 Dec;37:68-74. doi: 10.1016/j.ceb.2015.10.001. Epub 2015 Nov 11. Review.

5.

Inhibition of pluripotency networks by the Rb tumor suppressor restricts reprogramming and tumorigenesis.

Kareta MS, Gorges LL, Hafeez S, Benayoun BA, Marro S, Zmoos AF, Cecchini MJ, Spacek D, Batista LF, O'Brien M, Ng YH, Ang CE, Vaka D, Artandi SE, Dick FA, Brunet A, Sage J, Wernig M.

Cell Stem Cell. 2015 Jan 8;16(1):39-50. doi: 10.1016/j.stem.2014.10.019. Epub 2014 Nov 13.

6.

Recognition of multivalent histone states associated with heterochromatin by UHRF1 protein.

Nady N, Lemak A, Walker JR, Avvakumov GV, Kareta MS, Achour M, Xue S, Duan S, Allali-Hassani A, Zuo X, Wang YX, Bronner C, Chédin F, Arrowsmith CH, Dhe-Paganon S.

J Biol Chem. 2011 Jul 8;286(27):24300-11. doi: 10.1074/jbc.M111.234104. Epub 2011 Apr 13.

7.

DNMT3L modulates significant and distinct flanking sequence preference for DNA methylation by DNMT3A and DNMT3B in vivo.

Wienholz BL, Kareta MS, Moarefi AH, Gordon CA, Ginno PA, Chédin F.

PLoS Genet. 2010 Sep 9;6(9):e1001106. doi: 10.1371/journal.pgen.1001106.

8.

Tandem E2F binding sites in the promoter of the p107 cell cycle regulator control p107 expression and its cellular functions.

Burkhart DL, Wirt SE, Zmoos AF, Kareta MS, Sage J.

PLoS Genet. 2010 Jun 24;6(6):e1001003. doi: 10.1371/journal.pgen.1001003.

9.

A systematic search for DNA methyltransferase polymorphisms reveals a rare DNMT3L variant associated with subtelomeric hypomethylation.

El-Maarri O, Kareta MS, Mikeska T, Becker T, Diaz-Lacava A, Junen J, Nüsgen N, Behne F, Wienker T, Waha A, Oldenburg J, Chédin F.

Hum Mol Genet. 2009 May 15;18(10):1755-68. doi: 10.1093/hmg/ddp088. Epub 2009 Feb 26.

PMID:
19246518
10.

A SPOT on the chromatin landscape? Histone peptide arrays as a tool for epigenetic research.

Nady N, Min J, Kareta MS, Chédin F, Arrowsmith CH.

Trends Biochem Sci. 2008 Jul;33(7):305-13. doi: 10.1016/j.tibs.2008.04.014. Epub 2008 Jun 4.

PMID:
18538573
11.

Reconstitution and mechanism of the stimulation of de novo methylation by human DNMT3L.

Kareta MS, Botello ZM, Ennis JJ, Chou C, Chédin F.

J Biol Chem. 2006 Sep 8;281(36):25893-902. Epub 2006 Jul 7.

Supplemental Content

Loading ...
Support Center